123 related articles for article (PubMed ID: 3229081)
1. Hypocalcemia response following calcitonin administration: lack of correlation with osteoclast number determined after histoenzymologic identification in osteoporosis.
Palle S; Chappard D; Vico L; Alexandre C
Clin Rheumatol; 1988 Sep; 7(3):354-8. PubMed ID: 3229081
[TBL] [Abstract][Full Text] [Related]
2. [Dynamic test of hypocalcemia induced by calcitonin as a mean of global evaluation of osteoclastic activity in vivo. A new method of interpretation and results in the breakdown of osteoporosis].
Colson F; Gioud M; Tebib JG; Mathieu M; Bouvier M
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):481-6. PubMed ID: 3616473
[No Abstract] [Full Text] [Related]
3. Evaluation of the osteoclastic population in iliac crest biopsies from 36 normal subjects: a histoenzymologic and histomorphometric study.
Palle S; Chappard D; Vico L; Riffat G; Alexandre C
J Bone Miner Res; 1989 Aug; 4(4):501-6. PubMed ID: 2816499
[TBL] [Abstract][Full Text] [Related]
4. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
Chesnut CH; Majumdar S; Newitt DC; Shields A; Van Pelt J; Laschansky E; Azria M; Kriegman A; Olson M; Eriksen EF; Mindeholm L
J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin.
McSheehy PM; Farina C; Airaghi R; Allievi E; Banfi S; Bertolini D; Ferni G; Frattola D; Oneta S; Pinza M
Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704
[TBL] [Abstract][Full Text] [Related]
6. Editorial: salmon calcitonin in the treatment of Paget disease.
Goldsmith RS
JAMA; 1975 Jun; 232(11):1156-7. PubMed ID: 1173622
[No Abstract] [Full Text] [Related]
7. Acute effects of calcitonin on osteoclasts in man.
Singer FR; Melvin KE; Mills BG
Clin Endocrinol (Oxf); 1976; 5 Suppl():333S-340S. PubMed ID: 1053251
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
Marie PJ; Caulin F
Bone; 1986; 7(1):17-22. PubMed ID: 3964494
[TBL] [Abstract][Full Text] [Related]
9. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139].
Fenton AJ; Martin TJ; Nicholson GC
J Cell Physiol; 1993 Apr; 155(1):1-7. PubMed ID: 8468357
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of osteoclastic activity in multiple myeloma: results of a randomized trial studying hypocalcemia induced by human and salmon calcitonin in 49 patients].
Fuzibet JG; Lejeune C; Lepeu G; Jaubert J; Sotto JJ; Peyron R
Rev Rhum Mal Osteoartic; 1991 Mar; 58(3):223-7. PubMed ID: 2057701
[TBL] [Abstract][Full Text] [Related]
11. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells.
Tsukamoto M; Menuki K; Murai T; Hatakeyama A; Takada S; Furukawa K; Sakai A
Bone; 2016 Apr; 85():70-80. PubMed ID: 26851124
[TBL] [Abstract][Full Text] [Related]
12. Bone resorption by isolated human osteoclasts in vitro: effects of calcitonin.
Murrills RJ; Shane E; Lindsay R; Dempster DW
J Bone Miner Res; 1989 Apr; 4(2):259-68. PubMed ID: 2728929
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of salmon calcitonin in multiple myeloma: a valuable method for serial evaluation of osteoclastic lesions and disease activity--a prospective study of 125 patients.
Bataille R; Legendre C; Sany J
J Clin Oncol; 1985 Feb; 3(2):229-36. PubMed ID: 3968553
[TBL] [Abstract][Full Text] [Related]
14. Effects of continuous calcitonin treatment on osteoclasts derived from cocultures of mouse marrow stromal and spleen cells.
Liu BY; Wang JT; Leu JS; Chiang CP; Hsieh CC; Kwan HW
J Formos Med Assoc; 2000 Feb; 99(2):140-50. PubMed ID: 10770029
[TBL] [Abstract][Full Text] [Related]
15. Whole-body irradiation inhibits the escape phenomenon of osteoclasts in bones of calcitonin-treated rats.
Nakamura T; Toyofuku F; Kanda S
Calcif Tissue Int; 1985 Jan; 37(1):42-5. PubMed ID: 3922595
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin responsiveness and receptor expression in porcine and murine osteoclasts: a comparative study.
Galvin RJ; Bryan P; Venugopalan M; Smith DP; Thomas JE
Bone; 1998 Sep; 23(3):233-40. PubMed ID: 9737345
[TBL] [Abstract][Full Text] [Related]
17. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
18. Effect of calcitonin on the rates of bone formation and resorption in the rat.
Baylink D; Morey E; Rich C
Endocrinology; 1969 Feb; 84(2):261-9. PubMed ID: 4974375
[No Abstract] [Full Text] [Related]
19. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
20. Effects of a one-year administration of phosphate and intermittent calcitonin on bone-forming and bone-resorbing cells in involutional osteoporosis: a histomorphometric study.
Alexandre C; Chappard D; Caulin F; Bertrand A; Palle S; Riffat G
Calcif Tissue Int; 1988 Jun; 42(6):345-50. PubMed ID: 3135102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
